3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Carcinoma, Hepatocellular
2
Neoplasms
1
Liver Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Sorafenib
222
lenvatinib
147
Bevacizumab
131
Nivolumab
87
atezolizumab
81
pembrolizumab
74
Radiosurgery
71
durvalumab
63
sintilimab
61
Oxaliplatin
60
Fluorouracil
56
Doxorubicin
47
tislelizumab
46
apatinib
45
Radiofrequency Ablation
44
Hepatectomy
43
camrelizumab
41
Leucovorin
41
Radiotherapy
40
tremelimumab
37
Magnetic Resonance Spectroscopy
36
regorafenib
34
Immune Checkpoint Inhibitors
30
Capecitabine
30
Folfox protocol
29
Cisplatin
28
cabozantinib
26
Gemcitabine
26
Cyclophosphamide
26
Ipilimumab
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Glutamyl Aminopeptidase
×
Gastrointestinal
×
Clear all
NCT05713994
2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
300 enrolled
NCT05717738
2024-06-13
CCGLC-008
Tongji Hospital
Recruiting
300 enrolled